openPR Logo
Press release

Nephrology and Urology Devices Market Global Key Trends & Forecast 2018

01-04-2017 06:08 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Nephrology and Urology Devices Market Global Key Trends &

The nephrology and urology devices market is highly fragmented in nature due to several sub-segments within the market. The field comprises devices for dialysis, lithotripsy, stents, neurostimulation, prostate treatment, among others. Dialysis represents the most prominent segment with a share worth over 75.0% in the total market. The three leaders in this segment as of 2011 estimations were Fresenius, Gambro, and Baxter. However, the 2012 acquisition of Gambro by Baxter has put the company ahead, particularly in dialysis devices, as Gambro was the second leading dialysis devices manufacturer. By 2017, the newly restructured union is expected to account for a market share of around 40%, which will put Fresenius behind in second place.

Other notable players in the global market for nephrology and urology devices are Nipro and Nikkiso. The sacral neuromodulation segment is currently led by Medtronic, which is predicted to be the only company in the field.

The global market for nephrology and urology devices is estimated to reach a valuation of US$20.5 bn by 2018, rising at a healthy CAGR during the forecast period of 2012 to 2018.

Request a PDF Brochure with Report Analysis:

Dialysis Equipment Remains in Demand

Dialysis equipment has emerged as the most prominent segment in the global market for nephrology and urology devices, followed by devices treating kidney and bladder stones. The dialysis equipment market comprises dialyzers required for filtration. The report observes that the trend is shifting from the use of reusable dialyzers to disposable ones. This has been advised and accepted in order to decrease the rate of infection arising from reusable dialyzers and the increasing incidence of blood-related diseases. The incontinence and prolapse devices segment is also likely to exhibit a healthy growth rate.

Geographically, Europe was estimated to be the most significant market in the nephrology and urology devices market, followed by North America. Europe led the key markets of dialysis and sacral neurostimulation. North America is expected to expand its sacral neurostimulation market in coming years and nibble into the share of Europe. Asia Pacific is expected to be remain in the third place, followed by Rest of the World.

Swelling Diabetic Population Driving Demand

According to current statistics by the National Health and Nutrition Examination Survey (NHANES) and National Kidney Foundation, more than 26 million Americans have chronic kidney diseases (CKD) and about 20 million are living with hypertension or diabetes. Incidences of CKD in other region such as Asia Pacific, Europe, and the Middle East are also rising quickly with increasing geriatric population, consequently driving the global market for nephrology and urology devices. Other factors that will favor the expansion of this market are: the growing popularity of minimally invasive and non-invasive treatment procedures, the rising market for advanced lithotripters in developed regions, innovation and new product development to improve the efficacy of urology disease treatment process, and favorable healthcare policies, especially in developed countries.

Conversely, factors that may hinder the growth rate of the global market for nephrology and urology devices include: high installation prices of lithotripters devices and advanced machines, the slow growth in healthcare spending in developed markets, and the lack of awareness about advanced technologies in emerging markets.

According to the author of the report, “Traditionally price-sensitive markets in the regions of Asia Pacific and the Middle East are providing new opportunities with many healthcare providers adopting advanced technologies that can satisfy the needs of a growing patient base and also fit into their budget. Government initiatives towards improving healthcare infrastructure in these regions is also aiding the expansion of the nephrology and urology devices market.”

The information presented in this review is based on a Transparency Market Research report, titled, “Nephrology and Urology Devices Market (Dialysis Equipment, Lithotripsy, Ureteral and Prostatic Stents, Urethral Inserts, Pessaries, Pelvic Organ Prolapse, Benign Prostatic Hyperplasia) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012–2018.”

Browse Full Research Report on Nephrology and Urology Devices Market:

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.


Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Browse market research blog:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nephrology and Urology Devices Market Global Key Trends & Forecast 2018 here

News-ID: 404431 • Views: 332

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases

More Releases for Nephrology

Global Nephrology And Urology Devices Market Segments And Insights
The nephrology and urology devices (or) equipment market consists of sales of nephrology and urology devices and related services by entities (organizations, sole traders and partnerships) that produce nephrology and urology devices used in diagnosis and treatment of kidney and genitourinary diseases. This industry includes establishments that produce dialysis devices used during kidney failures and kidney disfunctioning, urinary stone treatment devices used in treating kidney stones, urinary incontinence & pelvic
20th Edition of International Conference on Clinical Nephrology
20th Edition of International Conference on Clinical Nephrology focuses on the undiscovered phases of Nephrology look into which gives a peerless opportunity to researchers everywhere throughout the world to take an interest, share and distinguish new considerations and furthermore exploration work. Our theme "Exploring the new technologies in Clinical Nephrology” centres on understanding the obscure realities of the Nephrology and its research. The two day conference clinches the workshops and
23rd European Nephrology Conference
23rd European Nephrology Conference is the world’s leading conference for Nephrology professionals to gather and contribute their research for developing the new techniques in the field of Nephrology. Nephrology Conferences offers over 30 sessions from different areas in the field of Nephrology in the form of Keynote, Plenary and workshop sessions including oral and poster presentations. Nephrology Conferences which is going to be held in global & ancient city Rome, Italy
A Technical Hunt on Innovations to Foster Nephrology at Annual Nephrology 2018
May 3, 2018: PULSUS Group, host of 18th Annual Conference on Nephrology, the Conference that discusses the Advanced trends of treatment and diagnosing methods of Kidney diseases. Annual Nephrology 2018 slated during September 12-13, 2018 at Holiday Inn Atrium, Singapore will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Nephrology, Urology & Pediatrics fields across the world. The Nephrology conference scientific program paves
Nephrology and Urology Devices Global Market Size, Share, Trend, Vendor Analysis …
According to Publisher, the Global Nephrology and Urology Devices is valued at $17.28 billion in 2015 and is expected to grow at a CAGR of 7.2% to reach $28.27 billion by 2022. Rising occurrence of chronic kidney diseases, increased spending on healthcare among the emerging regions and growing aged population across the world are some of the factors favoring the market growth. Moreover, the growing awareness about the benefits of
Nephrology and Urology Devices Market USD 22.5 Billion by 2020
The global nephrology and urology devices market is estimated to reach USD 22.5 Billion in 2020, growing at a CAGR of 5.9% from 2016 to 2020, according to a market research report Nephrology and Urology Devices Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Nephrology and Urology Devices Market 2013-2020 report at The global nephrology and urology devices market report provides market size (Revenue USD Million 2013 to 2020), market